Inactive Instrument

Insiders PLx Pharma Winddown Corp.

Equities

Plx Pharma Winddown Corp. Announces Resignation of Natasha Giordano as Chief Executive Officer	23-07-07	CI
Plx Pharma Winddown Corp. Announces Resignation of Rita Oâ€™Connor as Chief Financial Officer	23-07-07	CI
Plx Pharma Winddown Corp. Announces Executive Changes	23-07-07	CI
PLx Pharma Inc. Announces Resignation of John W. Hadden II as Member of Board	23-01-20	CI
Insider Trends: 90-Day Buying Trend Extended with Insider Purchase of Plx Pharma Stock	20-11-20	MT
PLx Pharma Inc. Announces Executive Changes	20-04-23	CI
PLx Pharma Inc. Appoints Tony Bartsh as Member to its Board of Directors	19-03-08	CI
PLx Pharma Inc. Appoints Efthymios Deliargyris as Chief Medical Officer	18-08-31	CI
PLx Pharma Inc. Announces Resignation of David P. Luci as Member of Board of Directors	17-10-27	CI
PLx Pharma Inc. Announces Executive Appointments	17-09-19	CI
PLx Pharma Inc. Adds Efthymios N. Deliargyris as Chief Medical Advisor	17-09-13	CI
Rita M. O’Connor Appointed Chief Financial Officer of PLx Pharma	17-05-02	GL
PLx Pharma Inc. Appoints Michael J. Dillon as Vice President, Sales and Marketing, Effective May 1, 2017	17-05-01	CI
PLx Pharma Inc. Announces Management Changes	16-12-22	CI
PLx Pharma Inc. Announces Management Changes	16-01-04	CI
Food and Drug Administration Accepts Review of PLx Pharma Inc.'s New Drug Application for PL2200 Aspirin 325 mg; Appoints Peter Mann to its Board of Directors	12-05-22	CI

No results for this search